Physician profile
Phillip M Pinell
NPI 1922009463
$1,549.68
in general payments reported to CMS, 2019-2025
22 companies · $258 in 2025
The $258 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.18 · 2020: $229 · 2021: $198 · 2022: $229 · 2023: $210 · 2024: $355 · 2025: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $822.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $822.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $249.98 | 2019-2024 | Slynd, Nuvessa, Tyblume |
| Abbvie INC. | $237.48 | 2020-2022 | |
| Mayne Pharma Commercial LLC | $135.67 | 2022-2024 | |
| Millicent US INC | $127.58 | 2023-2025 | Intrarosa, Femring, Femlyv |
| Boston Scientific Corporation | $106.56 | 2020 | |
| Pfizer INC. | $85.78 | 2023-2025 | |
| Hologic Sales and Service, LLC | $83.22 | 2021-2025 | Aptima |
| Medtronic, INC. | $76.39 | 2025 | V-Loc 180 |
| Avion Pharmaceuticals | $74.28 | 2021-2023 | Balcoltra |
| Astellas Pharma US INC | $57.77 | 2024 | Veozah |
| Allergan, INC. | $52.72 | 2019-2020 | |
| Amgen INC. | $45.92 | 2024-2025 | Evenity, Prolia |
| Integra Lifesciences Corporation | $43.52 | 2025 | Codman Certas, Duraseal Exact Spinal Sealant System, Cusa Clarity |
| Aspira Women'S Health INC | $26.79 | 2022 | |
| Dexcom, INC. | $22.52 | 2025 | Dexcom G6 Transmitter |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $20.66 | 2023 | Cologuard Collection Kit |
| Vertical Pharmaceuticals, LLC | $20.33 | 2019 | |
| Coopersurgical, INC. | $18.73 | 2023 | Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $18.07 | 2019 | |
| Ascend Therapeutics US, LLC | $17.19 | 2024 | |
| Therapeuticsmd, INC. | $17.09 | 2020 | |
| Minerva Surgical, INC | $11.43 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Pinell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.